Shield Therapeutics PLC Aktie
Finanztrends
Deine Einschätzung
Shield Therapeutics PLC Aktie
Ein erheblicher Verlust bei Shield Therapeutics PLC heute, um -30,33 %.
Was spricht für und gegen Shield Therapeutics PLC in den nächsten Jahren?
Pro
?
U****************
?
A****************
?
W******* i* V********
Kontra
?
M****
?
M************
?
L*********** I********** f** d** n******* J****
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Shield Therapeutics PLC im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | -30,33 % | -37,50 % | -37,50 % | -18,27 % | -59,52 % | -71,09 % | -91,36 % |
| Card Factory plc | 3,14 % | 8,93 % | 15,72 % | -25,61 % | 12,37 % | -15,45 % | 27,46 % |
| Pets At Home Group Ls 1 | -0,32 % | 8,19 % | 19,42 % | -5,19 % | 8,19 % | -46,35 % | -55,24 % |
| Natural Grocers By Vit. Cot. | -2,11 % | 8,59 % | 2,96 % | -15,24 % | 29,91 % | 150,45 % | 194,18 % |
Kommentare
News
Church & Dwight Q2 Earnings Call Highlights
Key Points
- Interested in Church & Dwight Co., Inc.? Here are five stocks we like better.
- Church & Dwight exceeded Q2 expectations, with net sales up 1.6%, organic sales up 5.8% and adjusted EPS
Exagen Q1 Earnings Call Highlights
Exagen (NASDAQ:XGN) reported record first-quarter revenue and reaffirmed its full-year outlook, as executives said growth in testing volume, improved reimbursement execution and expanding clinician
What Is the "Achilles Shield" and How Is Lockheed Martin Involved? Here's What Investors Need to Know.
Greece's air-defense capabilities will soon be getting an upgrade. That's the chief takeaway from the country's recent vote by the Special Permanent Parliamentary Committee on Armaments Programs and
